0001428690 · Multi-Asset · Closed-end fund
Crowding: 0 of 1 resolved names held by 3+ tracked funds · Crowded share not computed: this book does not reconcile (positions sum to 67% of the reported total). · Issuers are matched on normalised name (~10% measured error each way), so crowding and overlap figures are floors. How this is measured → · full readout →
Money leaving this fund each month, read off its own filed N-PORT flows — redemptions against the net assets they were redeemed out of, never annualised, so one heavy month reads as itself rather than multiplied by twelve.
$0M redeemed
These flows are Form N-PORT, which only registered funds file — interval, tender-offer and closed-end funds. BDCs repurchase shares through a separate tender-offer mechanism that is not this form, so this section is absent on a BDC's page rather than reported as zero. 3.0%+ / 5.0%+ of net assets in a single month are the live elevated / high edges. every fund ranked by redemption pressure →
Source: AltsVault · SEC filings · as of 2025-06-30
1 positions as of 2025-06-30 · position-level holdings (SEC N-PORT).
These positions sum to 67% of the fund's reported total, so individual values are not exact. Positions are taken from the fund's own N-PORT filing; the gap is usually non-USD positions, which are excluded, or derivative exposure the total treats differently. Names and relative sizes are indicative; the figures are not.
| Company | Fair value | Weight |
|---|---|---|
| Roivant Sciences LTD | $1M | 100.0% |
Crowded share not computed: this book does not reconcile (positions sum to 67% of the reported total).
0 of 1 resolved names are held by 3+ tracked funds · Issuers are matched on normalised name (~10% measured error each way), so crowding and overlap figures are floors. How this is measured →
Source: AltsVault · SEC filings
10 metrics reported by this fund.